Inactive Instrument

UEC Group Ltd.

Equities

002642

CNE1000019S2

Beijing Yilian Technology Co., Ltd. won an auction to acqure 35% stake in Zhongshuilian Technology Co., Ltd. from Ronglian Group Ltd. for CNY 3.2 million.

January 26, 2024

Beijing Yilian Technology Co., Ltd. won an auction to acqure 35% stake in Zhongshuilian Technology Co., Ltd. from Ronglian Group Ltd. (SZSE:002642) for CNY 3.2 million on January 26, 2024. Beijing Yilian Technology Co., Ltd. agreed to acquire 35% stake in Zhongshuilian Technology Co., Ltd. from Ronglian Group Ltd. recently. The transaction was approved by the board of Ronglian Group.

Latest news about UEC Group Ltd.

Ronglian Group Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Beijing Yilian Technology Co., Ltd. won an auction to acqure 35% stake in Zhongshuilian Technology Co., Ltd. from Ronglian Group Ltd. for CNY 3.2 million.	Jan. 26	CI
Ronglian Group Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Ronglian Group Ltd.(XSEC:002642) added to S&P Global BMI Index	23-09-18	CI
Ronglian Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Ronglian Group Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Ronglian Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20	CI
Ronglian Group Ltd. cancelled the transaction announced on January 15, 2021	23-02-08	CI
Ronglian Group Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Ronglian Group Ltd. Elects Li Li and Sun Xiushun as Non-Independent Directors	22-09-09	CI
Ronglian Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Ronglian Group Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Ronglian Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-21	CI
Ronglian Group Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Ronglian Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Ronglian Group Ltd. Approves Election Directors	21-05-25	CI
Ronglian Group Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Sector Update: Energy Stocks Rising Following Recent Reversal for Crude Oil	21-03-19	MT
Uranium Energy : to Sell 10 Million Shares to Institutional Investors	21-03-19	MT
Uranium Energy : Completes Additional Uranium Purchases; Launches $30.5 Million Stock Offering	21-03-17	MT
Shandong Jingda Technology Industry Development Co., Ltd signed a share transfer framework agreement to acquire 8% stake in Ronglian Group Ltd. from Wang Donghui and Wu Min for approximately CNY 320 million.	21-01-15	CI
Ronglian Group Ltd. announced that it expects to receive CNY 379 million in funding from Shandong Jingda Technology Industry Development Co., Ltd.	21-01-14	CI
Qi Xiaoxia signed the share transfer agreement to acquire an additional 2% stake in Ronglian Group Ltd. from Wang Donghui for CNY 50.5 million.	20-11-20	CI
Ronglian Group Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-29	CI
Ronglian Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-26	CI

Chart UEC Group Ltd.

Duration

Period

More charts

Company Profile

Ronglian Group Ltd, formerly UEC Group Ltd, is an industry Cloud Computing and data platform solutions and service providers. The Company operates through three main segments. The Enterprises Services segment is engaged in the provision of comprehensive solutions for enterprises through integrated planning consultation, system integration, professional operation and maintenance and special services. This segment is also engaged in the intelligent city, enterprise cloud computing and other fields. The Internet of Things segment is engaged in the provision of data acquisition and access products to support the construction and operation of Internet of Vehicles, Internet of Water and others. The Bio-medical segment is involved in the research and development of biological could platform.

Sector

More about the company